1st Quarter - Report
FOLEY HOAG LLP for ELI LILLY AND COMPANY
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| J KEVIN BRENNAN | — |
| PAUL KIM | — |
| NICK LITTLEFIELD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.